[HTML][HTML] The four epidemiological stages in the global evolution of inflammatory bowel disease
GG Kaplan, JW Windsor - Nature reviews Gastroenterology & …, 2021 - nature.com
Inflammatory bowel disease (IBD) is a global disease; its evolution can be stratified into four
epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence …
epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence …
Evolving epidemiology of IBD
JW Windsor, GG Kaplan - Current gastroenterology reports, 2019 - Springer
Abstract Purpose of Review Once thought a disease of Western civilizations, the
inflammatory bowel diseases (IBD) impose a global burden, now penetrating populations in …
inflammatory bowel diseases (IBD) impose a global burden, now penetrating populations in …
Cross talk between gut microbiota and intestinal mucosal immunity in the development of ulcerative colitis
J Zou, C Liu, S Jiang, D Qian, J Duan - Infection and Immunity, 2021 - Am Soc Microbiol
Ulcerative colitis (UC), a nonspecific inflammatory disease, is characterized by inflammation
and mucosal damage in the colon, and its prevalence in the world is increasing …
and mucosal damage in the colon, and its prevalence in the world is increasing …
[HTML][HTML] Vedolizumab: potential mechanisms of action for reducing pathological inflammation in inflammatory bowel diseases
M Luzentales-Simpson, YCF Pang, A Zhang… - Frontiers in Cell and …, 2021 - frontiersin.org
Inflammatory bowel diseases (IBD), encompassing ulcerative colitis (UC), and Crohn's
disease (CD), are a group of disorders characterized by chronic, relapsing, and remitting, or …
disease (CD), are a group of disorders characterized by chronic, relapsing, and remitting, or …
Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study
TJ Pasvol, L Horsfall, S Bloom, AW Segal, C Sabin… - BMJ open, 2020 - bmjopen.bmj.com
Objectives We describe temporal trends in the recorded incidence of inflammatory bowel
disease (IBD) in UK primary care patients between 2000 and 2018. Design A cohort study …
disease (IBD) in UK primary care patients between 2000 and 2018. Design A cohort study …
A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014
A Forss, M Clements, D Bergman… - Alimentary …, 2022 - Wiley Online Library
Background Epidemiological studies have shown inconsistent incidence rates (IRs) for
inflammatory bowel disease (IBD). Aim To assess the incidence and temporal trends of IBD …
inflammatory bowel disease (IBD). Aim To assess the incidence and temporal trends of IBD …
[HTML][HTML] Inflammatory bowel disease prevalence: surveillance data from the US National Health and Nutrition Examination Survey
MH Weisman, O Stens, HS Kim, JK Hou… - Preventive Medicine …, 2023 - Elsevier
Determining the overall US prevalence of Inflammatory Bowel Disease (IBD) is essential to
national level prevention programs and population risk assessment; however currently US …
national level prevention programs and population risk assessment; however currently US …
[HTML][HTML] Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3
X Ma, Q Di, X Li, X Zhao, R Zhang, Y Xiao, X Li… - Frontiers in …, 2022 - frontiersin.org
Inflammatory bowel diseases (IBDs) are increasingly common diseases characterized by
chronic and relapsing inflammation of the gastrointestinal tract. NLRP3 might be a crucial …
chronic and relapsing inflammation of the gastrointestinal tract. NLRP3 might be a crucial …
The multifaceted virulence of adherent-invasive Escherichia coli
S Mansour, T Asrar, W Elhenawy - Gut Microbes, 2023 - Taylor & Francis
The surge in inflammatory bowel diseases, like Crohn's disease (CD), is alarming. While the
role of the gut microbiome in CD development is unresolved, the frequent isolation of …
role of the gut microbiome in CD development is unresolved, the frequent isolation of …
Current strategies and potential prospects of nanomedicine-mediated therapy in inflammatory bowel disease
Inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis are highly
debilitating. IBDs are associated with the imbalance of inflammatory mediators within the …
debilitating. IBDs are associated with the imbalance of inflammatory mediators within the …